SEARCH

SEARCH BY CITATION

References

  • 1
    Yach, D., Stuckler, D., and Brownell, K. D. (2006) Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med. 12, 6266.
  • 2
    Department of Health and Human Services—Center for disease Control and Prevention. (2011) Obesity and overweight trends in the U.S. Available at: http://www.cdc.gov/nccdphp/dnpa/obesity/trend/index.htm.
  • 3
    Anderson, S. E. and Whitaker, R. C. (2009) Prevalence of obesity among US preschool children in different racial and ethnic groups. Arch. Pediatr. Adolesc. Med. 163, 344348.
  • 4
    Wilson, P. W. F., D'Agostino, R. B., Sullivan, L., Parise, H., and Kannel, W. B. (2002) Overweight and obesity as determinants of cardiovascular risk—the Framingham experience. Arch. Intern. Med. 162, 18671872.
  • 5
    Hall, J. E., Crook, E. D., Jones, D. W., Wofford, M. R., et al. (2002) Mechanisms of obesity-associated cardiovascular and renal disease. Am. J. Med. Sci. 324, 127137.
  • 6
    Davy, K. P. and Hall, J. E. (2004) Obesity and hypertension: two epidemics or one? Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R803R813.
  • 7
    Hall, J. E. (2003) The kidney, hypertension, and obesity. Hypertension 41, 625633.
  • 8
    Hypponen, E., Virtanen, S. M., Kenward, M. G., Knip, M., Akerblom, H. K., et al. (2000) Obesity, increased linear growth, and risk of type 1 diabetes in children. Diab. Care 23, 17551760.
  • 9
    Vaz, M., Jennings, G., Turner, A., Cox, H., Lambert, G., et al. (1997) Regional sympathetic nervous activity and oxygen consumption in obese normotensive subjects. Circulation 18, 34233429.
  • 10
    Davy, K. P. and Orr, J. S. (2009) Sympathetic nervous system behavior in human obesity. Neurosci. Biobehav. Rev. 33, 116124.
  • 11
    Hall, J. E., da Silva, A. A., do Carmo, J. M., Dubinion, J., Hamza, S., et al. (2010) Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J. Biol. Chem. 285, 1727117276.
  • 12
    Wofford, M. R., Anderson, D. C., Brown, C. A., Jones, D. W., Miller, M. E., et al. (2001) Antihypertensive effect of alpha and beta adrenergic blockade in obese and lean hypertensive subjects. Am. J. Hypertens. 14, 694698.
  • 13
    Kassab, S., Kato, T., Wilkins, F. C., Chen, R., Hall, J. E., et al. (1995) Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 25, 893897.
  • 14
    Straznicky, N. E., Eikelis, N., Lambert, E. A., and Esler, M. D. (2008) Mediators of sympathetic activation in metabolic syndrome obesity. Curr. Hypertens. Rep. 10, 440447.
  • 15
    Mancia, G., Bousquet, P., Elghozi, J. L., Esler, M., Grassi, G., et al. (2007) The sympathetic nervous system and the metabolic syndrome. J. Hypertens. 25, 909920.
  • 16
    da Silva, A. A., do Carmo, J. M., Dubinion, J., and Hall, J. E. (2009) The role of the sympathetic nervous system in obesity-related hypertension. Curr. Hypertens. Rep. 11, 20611.
  • 17
    Schwartz, M. W., Woods, S. C., Porte, D., Jr., Seeley, R. J., and Baskin, D. G. (2000) Central nervous system control of food intake. Nature 404, 661671.
  • 18
    Farooqi, S. and O'Rahilly, S. (2006) Genetics of obesity in humans. Endocr. Rev. 27, 710718.
  • 19
    Ozata, M., Ozdemir, I. C., and Licinio, J. (1999) Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J. Clin. Endocrinol. Metab. 10, 36863695.
  • 20
    Mark, A. L., Shafer, R. A., Correia, M. L., Morgan, D. A., Sigmund, C. D., et al. (1999) Contrasting blood pressure effects of obesity in leptin deficient ob/ob mice and agouti yellow obese mice. J. Hypertens. 17, 19491953.
  • 21
    Cohen, P., Connie, Z., Cai, X., Montez, J. M., Rohani, S. C., et al. (2001) Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest. 108, 11131121.
  • 22
    do Carmo, J. M., Bassi, M., da Silva, A. A., and Hall, J. E. (2008) Control of cardiovascular, metabolic and respiratory functions during prolonged obesity in leptin-deficient and diet-induced obese mice. Hypertension 15, 109.
  • 23
    Kalil, G. Z. and Haynes, W. G. (2012) Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens. Res. 35, 416.
  • 24
    Correia, M. L., Haynes, W. G., Rahmouni, K., Morgan, D. A., Sivitz, W. I., et al. (2002) The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 51, 439442.
  • 25
    Rahmouni, K., Fath, M. A., Seo, S., Thedens, D. R., Berry, C. J., et al. (2008) Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J. Clin. Invest. 118, 14581467.
  • 26
    Rahmouni, K., Morgan, D. A., Morgan, G. M., Mark, A. L., and Haynes, W. G. (2005) Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54, 20122018.
  • 27
    Shek, E. W., Brands, M. W., and Hall, J. E. (1998) Chronic leptin infusion increases arterial pressure. Hypertension 31, 409414.
  • 28
    Carlyle, M., Jones, O. B., Kuo, J. J., and Hall, J. E. (2002) Chronic cardiovascular and renal actions of leptin-role of adrenergic activity. Hypertension 39, 496501.
  • 29
    Aizawa-Abe, M., Ogawa, Y., Masuzaki, H., Ebihara, K., Satoh, N., et al. (2000) Pathophysiological role of leptin in obesity-related hypertension. J. Biol. Chem. 105, 12431252.
  • 30
    Prior, L. J., Eikelis, N., Armitage, J. A., Davern, P. J., Burke, S. L., et al. (2010) Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 55, 862868.
  • 31
    Mark, A. L., Correia, M. L., Rahmouni, K., and Haynes, W. G. (2002) Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J. Hypertens. 20, 12451250.
  • 32
    Ghilardi, N. and Skoda, R. C. (1997) The leptin receptor activates Janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrinol. 11, 393399.
  • 33
    Gao, Q., Wolfgang, M. J., and Neschen, S. (2004) Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc. Natl. Acad. Sci. USA. 101, 46614666.
  • 34
    Dubinion, J. H., do Carmo, J. M., Adi, A., Hamza, S., da Silva, A. A., et al. (2013) Role of proopiomelanocortin neuron Stat3 in regulating arterial pressure and mediating the chronic effects of leptin. Hypertension 61, 10661074.
  • 35
    Rahmouni, K., Haynes, W. G., Morgan, D. A., and Mark, A. L. (2002) Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension 41, 763767.
  • 36
    Choudhury, A. I., Heffron, H., Smith, M. A., Al-Qassab, H., Xu, A. W., et al. (2005) The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J. Clin. Invest. 15, 940950.
  • 37
    Lin, X., Taguchi, A., Park, S., Kushner, J. A., Li, F., et al. (2004) Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J. Clin. Invest. 114, 908916.
  • 38
    Burks, D., de Mora, J. F., Schubert, M., Withers, D.J., Myers, M. G., et al. (2000) IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407, 377382.
  • 39
    Krajewska, M., Banares, S., Zhang, E. E., Huang, X., Scadeng, M., et al. Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase. Am. J. Pathol. 172, 13121324.
  • 40
    Zhang, E. E., Chapeau, E., Hagihara, K., and Feng, G. S. (2004) Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc. Natl. Acad. Sci. USA. 9, 1606416069.
  • 41
    Kloek, C., Haq, A. K., Dunn, S. L., Lavery, H. J., Banks, A. S., et al. (2002) Regulation of Jak kinases by intracellular leptin receptor sequences. J. Biol. Chem. 277, 4154741555.
  • 42
    Vong, L., Ye, C., Yang, Z., Choi, B., Chua, S. Jr., et al. (2011) Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron 71, 142154.
  • 43
    Harlan, S. M., Morgan, D. A., Agassandian, K., Guo, D. F., Cassell, M. D., et al. (2011) Ablation of the leptin receptor in the hypothalamic arcuate nucleus abrogates leptin-induced sympathetic activation. Circ. Res. 108, 808812.
  • 44
    do Carmo, J. M., da Silva, A. A., Cai, Z., Lin, S., Dubinion, J. H., et al. (2011) Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension 57, 918926.
  • 45
    Myers, M. P., Anderson, J. N., Cheng, A., Tremblay, M. L., Horvath, C. M., et al. (2001) TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276, 4777147774.
  • 46
    Belin de Chantemele, E. J., Muta, K., Mintz, J., Tremblay, M. L., Marrero, M. B., et al. (2009). Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function. Circulation 120, 753763.
  • 47
    Bjorbaek, C., El-Haschimi, K., Frantz, J. D., and Flier, J. S. (1999) The role of SOCS3 in leptin signaling and leptin resistance. J. Biol. Chem. 274, 3005930065.
  • 48
    Mori, H., Hanada, R., Hanada, T., Aki, D., Mashima, R., et al. (2004) Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat. Med. 10, 739743.
  • 49
    Tallam, L. S., Stec, D. E., Willis, M. A., da Silva, A. A., and Hall, J. E. (2005) Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension 46, 326332.
  • 50
    Tallam, L. S., da Silva, A. A., and Hall, J. E. (2006) Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48, 5864.
  • 51
    da Silva, A.A., do Carmo, J. M., Kanyicska, B., Dubinion, J., Brandon, E., et al. (2008) Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension 51, 884890.
  • 52
    Kievit, P., Halem, H., Marks, D. L., Dong, J. Z., Glavas, M. M., et al. (2013) Chronic treatment with a melanocortin 4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese Rhesus Macaques. Diabetes 62, 490497.
  • 53
    Greenfield, J. R. (2011) Melanocortin signaling and the regulation of blood pressure in human obesity. J. Neuroendocrinol. 23, 186193.
  • 54
    Sayk, F., Heutling, D., Dodt, C., Iwen, K. A., Wellhoner, J. P., et al. (2002) Sympathetic function in human carriers of melanocortin-4 receptor gene mutations. J. Clin. Endocrinol. Metab. 95, 19982002.
  • 55
    Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., et al. (2009) Modulation of blood pressure by central melanocortinergic pathways. N. Engl. J. Med. 360, 4452.
  • 56
    Balthasar, N., Dalgaard, L. T., Lee, C. E., Yu, J., Funahashi, H., et al. (2005) Divergence control of melanocortin pathways in the control of food intake and energy expenditure. Cell 123, 493505.
  • 57
    do Carmo, J. M., da Silva, A. A., Rushing, J. S., Dubinion, J., Hall, M., et al. (2011) Differential control of appetite and cardiovascular function after selective rescue of melanocortin-4 receptor in proopiomelanocortin neurons. Hypertension 12, 380.
  • 58
    do Carmo, J. M., da Silva, A. A., Rushing, J. S., and Hall, J. E. (2012) Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R561R567.
  • 59
    Ma, X., Zubcevic, L., and Ashcroft, F. M. (2008) Glucose regulates the effects of leptin on hypothalamic POMC neurons. Proc. Natl. Acad. Sci. USA. 105, 98119816.
  • 60
    Plum, L., Belgardt, B., and Bruming, J. (2006) Central insulin action in energy and glucose homeostasis. J. Clin. Invest. 116, 17611766.
  • 61
    Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., et al. (2002) Gut hormone PYY (3–36) physiologically inhibits food intake. Nature 418, 650654.
  • 62
    Blum, M., Roberts, J. L., and Wardlaw, S.L. (1989). Androgen regulation of proopiomelanocortin gene expression and peptide content in the basal hypothalamus. Endocrinology 124, 22832288.
  • 63
    Gao, Q., Mezei, G., Nie, Y., Choi, C. S., Bechmann, I., et al. (2007) Anorectic estrogen mimics leptin's effect on rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat. Med. 13, 8994.
  • 64
    Jo, Y. H., Su, Y., Gutierrez-Juarez, G., and Chua, S. (2009) Oleic acid directly regulates POMC neuron excitability in the hypothalamus. J. Neurophysiol. 101, 23052316.
  • 65
    Nicholson, J. R., Peter, J. C., Lecourt, A. C., Barde, Y. A., and Hofbauer, K. G. (2007) Melanocortin-4 receptor activation stimulates hypothalamic brain-derived neurotrophic factor release to regulate food intake, body temperature and cardiovascular function. J. Neuroendocrinol. 19, 974982.
  • 66
    Shimizu, H., Inoue, K., and Mori, M. (2007) The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure. J. Endocrinol. 193, 19.
  • 67
    Tolson, K. P., GEmelli, T., Elmquist, J. K., Zinn, A. R., and Kublaoui, B. M. (2010) Postnatal Sim1 deficiency causes hyperphagic obesity and reduced MC4R and oxytocin expression. J. Neurosci. 10, 38033812.